WithdrawnPHASE1, PHASE2NCT02141100

Study of 6-Thioguanine in Combination With 6-Mercaptopurine During Maintenance Therapy of Childhood Lymphoma

Studying Non-Hodgkin lymphoma

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Kjeld Schmiegelow
Principal Investigator
Kjeld Schmiegelow, M.D.
Rigshospitalet, Denmark
Intervention
6-thioguanine(drug)
Eligibility
2-18 years · All sexes
Timeline
2014 – 2016

Study locations (1)

Collaborators

Aalborg University Hospital · Aarhus University Hospital Skejby · Odense University Hospital

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02141100 on ClinicalTrials.gov

Other trials for Non-Hodgkin lymphoma

Additional recruiting or active studies for the same condition.

See all trials for Non-Hodgkin lymphoma →

← Back to all trials